Neuraxis, Inc. Files Definitive Proxy Statement

Ticker: NRXS · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1933567

Neuraxis, INC DEF 14A Filing Summary
FieldDetail
CompanyNeuraxis, INC (NRXS)
Form TypeDEF 14A
Filed DateApr 14, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, regulatory-filing, shareholder-meeting

TL;DR

Neuraxis (NRXS) filed its proxy statement, shareholders vote soon.

AI Summary

Neuraxis, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 14, 2025, for its fiscal year ending December 31, 2025. The company, located in Carmel, Indiana, is involved in the electromedical and electrotherapeutic apparatus industry. This filing is a standard procedural document related to shareholder matters.

Why It Matters

This filing provides shareholders with essential information regarding upcoming company decisions and voting matters, impacting their investment in Neuraxis, Inc.

Risk Assessment

Risk Level: low — This is a routine regulatory filing and does not contain new financial information or strategic changes that would inherently increase risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.

When was this DEF 14A filed by Neuraxis, Inc.?

Neuraxis, Inc. filed this DEF 14A on April 14, 2025.

What is Neuraxis, Inc.'s primary business sector?

Neuraxis, Inc. is in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, with SIC code 3845.

Where is Neuraxis, Inc. located?

Neuraxis, Inc. is located at 11611 N. Meridian St, Suite 330, Carmel, IN 46032.

What is the filing date as of which this document is prepared?

The filing is as of April 14, 2025.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding Neuraxis, INC (NRXS).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing